Product Code: ETC8834501 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Amlodipine besylate, a cornerstone in hypertension management, holds a strong position in the Philippine pharmaceutical market. As cardiovascular diseases remain prevalent, demand for this antihypertensive continues to grow, supported by government health initiatives and generic product availability.
Amlodipine besylate, a common medication for hypertension and angina, is in high demand in the Philippines due to the increasing prevalence of cardiovascular diseases. Healthcare providers are focusing on affordable treatments, driving the growth of this market as part of national efforts to reduce heart disease.
Amlodipine is a widely used antihypertensive medication. The market is large and competitive, with generics dominating and public health programs supporting demand.
As hypertension cases rise, the amlodipine besylate market offers attractive investment potential in producing affordable generics, improving drug accessibility, and partnering with public health programs focused on cardiovascular care.
Amlodipine besylate, a first-line antihypertensive drug, is included in the national essential medicines list and widely distributed in government health facilities. PhilHealth provides coverage for hypertension management, while the DOH runs nationwide campaigns to improve cardiovascular health and medication adherence.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Amlodipine Besylate Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Amlodipine Besylate Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Amlodipine Besylate Market - Industry Life Cycle |
3.4 Philippines Amlodipine Besylate Market - Porter's Five Forces |
3.5 Philippines Amlodipine Besylate Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Philippines Amlodipine Besylate Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Philippines Amlodipine Besylate Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Amlodipine Besylate Market Trends |
6 Philippines Amlodipine Besylate Market, By Types |
6.1 Philippines Amlodipine Besylate Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Amlodipine Besylate Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Philippines Amlodipine Besylate Market Revenues & Volume, By 2.5mg Tablets, 2021- 2031F |
6.1.4 Philippines Amlodipine Besylate Market Revenues & Volume, By 5mg Tablets, 2021- 2031F |
6.1.5 Philippines Amlodipine Besylate Market Revenues & Volume, By 10mg Tablets., 2021- 2031F |
6.2 Philippines Amlodipine Besylate Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Philippines Amlodipine Besylate Market Revenues & Volume, By High Blood Pressure, 2021- 2031F |
6.2.3 Philippines Amlodipine Besylate Market Revenues & Volume, By Heart Diseases, 2021- 2031F |
7 Philippines Amlodipine Besylate Market Import-Export Trade Statistics |
7.1 Philippines Amlodipine Besylate Market Export to Major Countries |
7.2 Philippines Amlodipine Besylate Market Imports from Major Countries |
8 Philippines Amlodipine Besylate Market Key Performance Indicators |
9 Philippines Amlodipine Besylate Market - Opportunity Assessment |
9.1 Philippines Amlodipine Besylate Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Philippines Amlodipine Besylate Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Philippines Amlodipine Besylate Market - Competitive Landscape |
10.1 Philippines Amlodipine Besylate Market Revenue Share, By Companies, 2024 |
10.2 Philippines Amlodipine Besylate Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |